Facultad de Ciencias de la Salud
Facultad
Chelsea and Westminster Hospital
Londres, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von Chelsea and Westminster Hospital (6)
2016
-
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 1056-1062
2015
-
Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV
AIDS, Vol. 29, Núm. 5, pp. 571-581
2014
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
2013
-
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study
BMC Infectious Diseases, Vol. 13, Núm. 1
2008
-
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy
AIDS, Vol. 22, Núm. 14, pp. 1779-1787
2004
-
Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: Consensus recommendations
AIDS, Vol. 18, Núm. 8, pp. 1137-1146